NASDAQ:VRDN | Free Cash Flow | Viridian Therapeutics, Inc.\DE

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$119.65M$23,000.00-$119.68M
2025-12-31-$23.75M$240,000.00-$23.99M
2025-03-31-$92.65M$86,000.00-$92.74M
2024-12-31-$73.33M$114,000.00-$73.45M
2024-03-31-$45.22M$0.00-$45.22M
2023-12-31-$38M$48,000.00-$38.05M
2023-03-31-$61.97M$115,000.00-$62.09M
2022-12-31-$34.04M$231,000.00-$34.27M
2022-03-31-$21.04M$179,000.00-$21.22M
2021-12-31-$16.54M$84,000.00-$16.62M
2021-03-31-$11.54M$15,000.00-$11.55M
2020-12-31-$9.44M-$11,000.00-$9.45M
2020-03-31-$8.46M$0.00-$8.46M
2019-12-31-$7.81M$0.00-$7.81M
2019-03-31-$11.81M$37,000.00-$11.85M
2018-12-31-$8.18M$51,000.00-$8.23M
2018-03-31-$7.36M$95,000.00-$7.46M
2017-12-31-$7.24M$34,000.00-$7.28M
2017-03-31-$8.18M$44,000.00-$8.23M
2016-12-31-$3.29M$10,000.00-$3.3M
2016-03-31-$4.17M$105,000.00-$4.28M
2015-12-31-$1.3M$23,000.00-$1.32M
2015-03-31-$1.11M$44,000.00-$1.15M
2014-12-31-$997,000.00$262,000.00-$1.26M
2014-03-31$85,000.00
2013-12-31-$357,753.00$2,854.00-$360,607.00-988.45%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$276.39M$495,000.00-$276.89M
2024-12-31-$232.32M$511,000.00-$232.83M
2023-12-31-$184.17M$898,000.00-$185.07M
2022-12-31-$93.84M$797,000.00-$94.64M
2021-12-31-$54.58M$338,000.00-$54.92M
2020-12-31-$29.78M$42,000.00-$29.82M
2019-12-31-$36.06M$84,000.00-$36.14M
2018-12-31-$26.84M$445,000.00-$27.29M
2017-12-31-$28.17M$246,000.00-$28.41M
2016-12-31-$14.76M$250,000.00-$15.01M
2015-12-31-$6.9M$123,000.00-$7.02M
2014-12-31-$2.21M$266,000.00-$2.48M
2013-12-31-$1.17M$5,000.00-$1.17M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.